Caraco Pharmaceutical Laboratories. Recall Enterprise System (RES) recall details
Similar Posts
FDA Drug Competition Action Plan
FDA’s Drug Competition Action Plan (DCAP) encourages robust and timely market competition for generic drugs and helps bring greater efficiency and transparency to the generic drug review process, without sacrificing the scientific rigor underlying our generic drug program.Torrent Pharmaceuticals Limited – 585255 – 09/04/2024
CGMP/Finished Pharmaceuticals/AdulteratedDermaRite Industries Issues Voluntary Nationwide Recall of DermaKleen, Dermasarra, Kleenfoam, and Perigiene Products Due to Burkholderia cepacia Contamination
DermaRite Industries, LLC is voluntarily recalling individual lots of products in the table below due to microbial contamination identified as Burkholderia cepecia.What is a Medical Device Recall?
What is a Medical Device Recall?FDA In Brief: FDA approves new packaging for brand-name over-the-counter loperamide to help curb abuse and misuse
FDA approves new packaging for brand-name over-the-counter loperamide to help curb abuse and misuseBiomarker Qualification Program
The Drug Development Tools (DDT) Research Grant Cycle for Fiscal Years (FY) 2024 is now open.